Image

Cardiovascular Risk in Children With Chronic Conditions Study

Cardiovascular Risk in Children With Chronic Conditions Study

Recruiting
6-25 years
All
Phase N/A

Powered by AI

Overview

Children living with chronic health conditions face a higher risk of developing cardiovascular diseases than their peers, largely due to the accelerated aging of the heart and blood vessels. Although experts recognize this elevated risk and recommend close monitoring and early intervention, the underlying mechanisms driving this phenomenon remain poorly understood. At present, no effective interventions specifically target its root causes.

Recent research shows that both large blood vessels (such as the carotid artery) and small vessels (such as those in the retina) can display early signs of damage decades before clinically apparent heart or vascular disease emerges. This accelerated vascular aging can result from multiple factors - including disease-related processes such as persistent inflammation and metabolic disturbances, treatment-related effects such as chemotherapy or long-term steroid use, and lifestyle changes associated with chronic illness, such as reduced physical activity and altered eating habits. However, it is still unclear how these factors influence the development and progression of vascular changes in children as they grow. Importantly, these changes can be monitored through non-invasive methods, offering a unique opportunity to study at-risk patients many years before overt cardiovascular disease develops.

Identifying these early changes may enable us to detect and track individuals at heightened risk well in advance of clinical disease. This study aims to deepen our understanding of the causes of increased cardiovascular risk in children with chronic conditions and to lay the groundwork for earlier, more targeted prevention strategies.

Eligibility

Inclusion criteria:

  1. Individuals aged between 6 and 25 years;
  2. Diagnosed with a chronic childhood condition/disease associated with an increased risk of early cardiovascular disease;
  3. Provided informed consent (if over 18 years old) or had informed consent provided by their legal guardian (if under 18 years old) following appropriate information about the study.

Chronic childhood conditions/diseases associated with increased risk of early cardiovascular disease are defined according to the 2019 American Heart Association recommendations (https://doi.org/10.1161/CIR.0000000000000618), as well as other conditions/diseases for which at least two large-scale epidemiological studies have demonstrated an increased risk of cardiovascular disease.

Exclusion criteria:

  1. Severe intellectual and developmental disability;
  2. Decompensated heart failure;
  3. Severe primary immunodeficiency;
  4. Ongoing intravenous chemotherapy;
  5. Infectious diseases posing a public health risk; or
  6. History of regular alcohol or drug use.

Study details
    Kidney Transplant
    Familial Hypercholesterolaemia
    Type 1 Diabetes Mellitus (T1DM)
    Type 2 Diabetes Mellitus (T2DM)
    Chronic Kidney Disease
    Kawasaki Disease
    Liver Transplant
    Obesity and Overweight
    Hypertension
    Coarctation of Aorta
    Bone Marrow Transplant
    Cancer (Solid Tumors)
    Leukemia
    Lymphoma
    Lipoprotein(a)
    Aorta Stenosis
    Non Alcoholic Fatty Liver Disease
    Dyslipaemia
    White Coat Hypertension
    Pulmonary Hypertension
    Juvenile Idiopahtic Arthritis
    Systemic Lupus Erthematosus
    Inflammatory Bowel Disease (IBD)
    HIV Infection
    Transposition of Great Arteries

NCT07086989

Semmelweis University

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.